Cipla | CMP: Rs 1,146.05 | The scrip ended in the red even as the company reported a 10.9 percent on-year growth in consolidated net profit of Rs 788.9 crore for the quarter ended September, which was above the street expectation of Rs 771.3 crore. The drugmaker reported a 5.6 percent on-year rise in consolidated revenue from operations to Rs 5,828.4 crore, which was also above analysts' expectations of Rs 5,723.9 crore. The beat in the topline of the company was triggered by a better-than-expected performance in the North America business in the September quarter.

Moneycontrol Pro Panorama | GST reset fuels auto engine
Dec 2, 2025 / 03:01 PM IST
Moneycontrol Pro Panorama December 2 edition: RBI's liquidity measures clearer than rate cuts, revised tax regime could impact ITC...
Read NowAre you a PRO subscriber? Sign In
Ad free Experience
Seamless navigation, faster responses.
Expert Perspective
Explore 230+ exclusive editorials every month
+
Uncover Insights from World-Renowned Experts and Journalists
Actionable Insights
40+ weekly investment ideas + 3 to 4 daily technical calls
Virtual Events
Exclusive Live Webinars for Expert Trading & Investment Strategies!
Newsletters
Stay ahead with daily and weekly insights
Unlock exclusive discounts